Oxybutynin Tablet, Film Coated, Extended Release
Product Images NDC 50090-5353

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin (NDC 50090-5353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 01

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 02

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 03

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 04

This appears to be a partial label of a medication called "Oxybutynin chloride" in extended-release tablet form. It is unclear what the medication is specifically for without further context. Additionally, there is a mention of "placebo" and some numbers indicating a scale of some kind, but again, without proper context, it is difficult to determine what this information is referring to.*

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 05

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 06

Oxybutynin is a medication that comes in the form of extended-release tablets. The text also mentions "oxybutynin chloride". No further information is available.*

FDA Label Image

Label Image (Lbl500905353)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.